ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,734,268 | -28.8% | 8,420,493 | 0.0% | 0.01% | -20.0% |
| Q2 2023 | $54,396,385 | -22.7% | 8,420,493 | -9.7% | 0.01% | -33.3% |
| Q1 2023 | $70,329,297 | -25.6% | 9,327,493 | 0.0% | 0.02% | -25.0% |
| Q4 2022 | $94,487,504 | -0.3% | 9,327,493 | -2.6% | 0.02% | -4.8% |
| Q3 2022 | $94,754,000 | -31.8% | 9,580,759 | -26.5% | 0.02% | -27.6% |
| Q2 2022 | $138,859,000 | -22.0% | 13,038,357 | -28.6% | 0.03% | -6.5% |
| Q1 2022 | $178,111,000 | -43.5% | 18,267,775 | -17.2% | 0.03% | -38.0% |
| Q4 2021 | $315,339,000 | -20.6% | 22,051,703 | +11.3% | 0.05% | -26.5% |
| Q3 2021 | $397,221,000 | +34.6% | 19,821,407 | +47.8% | 0.07% | +36.0% |
| Q2 2021 | $295,140,000 | +108.9% | 13,415,437 | +222.4% | 0.05% | +92.3% |
| Q1 2021 | $141,303,000 | -3.5% | 4,160,870 | +14.3% | 0.03% | -7.1% |
| Q4 2020 | $146,450,000 | – | 3,639,423 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |